Can neurocognitive assessment be a lower-cost substitute for biomarkers in predicting progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? A narrative review

The challenge to find the best predictors of conversion from Mild Cognitive Impairment (MCI) to Alzheimer’s disease (AD) has been ongoing at least for the last decade. Nonetheless, clinicians still lack, to date, a robust predictive tool for identifying individuals who will go through this conversio...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lea Daou, Alaeddine El Alayli, Fadi Constantinos, Georgette Dib, Marc Barakat
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-12-01
Edice:	Biomarkers in Neuropsychiatry
Témata:	Mild cognitive impairment Alzheimer's disease Neurocognitive assessment Neuropsychological testing Predictive accuracy Biomarkers
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666144623000096
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!